Posterior uveal melanoma in 321 Asian Indian patients: analysis based on the 8th edition of American Joint Committee Cancer classification.
AJCC 8th edition
Choroid
Choroidal melanoma
Eye
Melanoma
Tumor
Uvea
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
21
02
2020
accepted:
22
06
2020
pubmed:
1
7
2020
medline:
22
6
2021
entrez:
1
7
2020
Statut:
ppublish
Résumé
To evaluate the presenting features, treatment, and outcomes of posterior uveal melanoma (PUM) in Asian Indians based on the 8th edition of American Joint Committee on Cancer (AJCC) classification. Retrospective interventional case series of 321 Asian Indian patients with PUM. Based on AJCC, PUM was classified into categories T1 (n = 36; 11%), T2 (n = 74; 23%), T3 (n = 126; 39%), and T4 (n = 85; 27%). Regarding tumor features, T4 was more likely to have pre-equatorial epicenter (vs T1 and T2; p ≤ 0.011), iris abnormalities (vs T2 and T3; p ≤ 0.002), and extraocular tumor extension (vs T3; p = 0.001), whereas T1 was more likely to have macular epicenter (vs T2, T3, T4; p ≤ 0.013), lipofuscin deposits (vs T3 and T4; p ≤ 0.008), and amelanotic tumors (vs. T4; p = 0.003). On multivariate analysis, factors predictive of systemic metastasis were increasing tumor thickness (p = 0.002) and extraocular tumor extension (p = 0.009). The 5-, 10-, and 15-year melanoma-related metastases rates were 0%, 0%, and 0% in T1, 0%, 60%, and 60% in T2, 7%, 40%, and 70% in T3 and 13%, 36%, and 76% in T4, respectively. Risk for metastasis was 1.23 times more for every 1-mm increase in tumor thickness and 9 times more with extraocular tumor extension. The AJCC 8th edition provides prognostic classification for PUM in Asian Indian patients. The significant risk factors for metastasis were increasing tumor thickness and extraocular tumor extension.
Identifiants
pubmed: 32601966
doi: 10.1007/s10792-020-01494-2
pii: 10.1007/s10792-020-01494-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3087-3096Références
Edge SB, Greene FL, Byrd DR et al (eds) (2017) AJCC cancer staging manual, 8th edn. Springer, New York
Edge SB, Byrd DR, Comptom CC et al (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York
Finger PT (2009) 7th edition, AJCC-UICC ophthalmic oncology task force. The 7
pubmed: 19653708
Kujala E, Kivelä T (2005) Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions. Ophthalmology 112(6):1135–1144
doi: 10.1016/j.ophtha.2004.11.063
AJCC Ophthalmic Oncology Task Force (2015) International validation of the American joint committee on cancer’s 7th edition classification of uveal melanoma. JAMA Ophthalmol 133(4):376–383
doi: 10.1001/jamaophthalmol.2014.5395
Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD, Kivelä T (2013) Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol 31(22):2825–2831
doi: 10.1200/JCO.2012.45.2771
Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA (2013) American joint committee on cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients. Ophthalmology 120(10):2066–2071
doi: 10.1016/j.ophtha.2013.03.012
Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA (2015) American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: the 2013 Zimmerman Lecture. Ophthalmology 122(6):1180–1186
doi: 10.1016/j.ophtha.2015.01.026
Bagger M, Andersen MT, Andersen KK, Heegaard S, Andersen MK, Kiilgaard JF (2014) The prognostic effect of American joint committee on cancer staging and genetic status in patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 56(1):438–444
doi: 10.1167/iovs.14-15571
Kaliki S, Shields CL (2017) Uveal melanoma: relatively rare but deadly cancer. Eye (Lond) 31(2):241–257
doi: 10.1038/eye.2016.275
Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA (2012) Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina 32(7):1363–1372
doi: 10.1097/IAE.0b013e31824d09a8
Kashyap S, Venkatesh P, Sen S, Khanduja S, Shrey D, Tinwala S, Garg S (2014) Clinicopathologic characteristics of choroidal melanoma in a North Indian population: analysis of 10-year data. Int Ophthalmol 34(2):235–239
doi: 10.1007/s10792-013-9821-8
Dhupper M, Biswas J, Gopal L, Kumar SK, Khetan V (2012) Clinicopathological correlation of choroidal melanoma in Indian population: a study of 113 cases. Oman J Ophthalmol 5(1):42–45
doi: 10.4103/0974-620X.94766
Biswas J, Kabra S, Krishnakumar S, Shanmugam MP (2004) Clinical and histopathological characteristics of uveal melanoma in Asian Indians. A study of 103 patients. Indian J Ophthalmol 52(1):41–44
pubmed: 15132378
Pal BP, Garge S, Khetan V (2017) Choroidal melanoma: a short review with an Indian perspective. Oman J Ophthalmol 10(3):135–144
doi: 10.4103/ojo.OJO_234_2016
Meeralakshmi P, Shah PK, Narendran V (2017) Experiences of two different modalities in the management of choroidal melanoma in the Asian Indian population. South Asian J Cancer 6(3):134–136
doi: 10.4103/sajc.sajc_160_16
Damato BE, Heimann H, Kalirai H, Coupland SE (2014) Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol 132(5):605–613
doi: 10.1001/jamaophthalmol.2014.77
Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL (2006) Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 166(17):1907–1914
doi: 10.1001/archinte.166.17.1907
Shields CL, Kaliki S, Cohen MN, Shields PW, Furuta M, Shields JA (2015) Prognosis of uveal melanoma based on race in 8100 patients: the 2015 Doyne Lecture. Eye (Lond) 29(8):1027–1035
doi: 10.1038/eye.2015.51